title: Improved exercise capacity with acute aminophylline administration in patients with syndrome X.
abstract: The efficacy of the adenosine receptor blocker aminophylline on exercise capacity in patients with effort ischemia and documented coronary artery disease has been previously documented. In this study the effect of aminophylline on effort electrocardiographic (ECG) alterations and chest pain was tested in eight patients with syndrome X (anginal chest pain on effort, ischemic ECG changes during exercise, positive dipyridamole test, normal epicardial coronary arteries on angiography and absence of coronary spasm after ergonovine). After double-blind, randomized intravenous infusion of aminophylline (6 mg/kg body weight over 15 min) or placebo (20 ml of saline solution over 15 min), the eight patients with syndrome X underwent an upright bicycle exercise stress test on 2 consecutive days. After aminophylline, there was an increase in effort tolerance (aminophylline 7.7 +/- 1.2 min of exercise versus placebo 5.6 +/- 0.9, p less than 0.01) paralleled by an increase of the rate-pressure product (mm Hg x beats/min x 1/100) at 0.1 mV of ST segment depression or at peak exercise (aminophylline 278 +/- 55 versus placebo 230 +/- 24, p less than 0.05). Aminophylline provoked the abolition of ECG signs of ischemia in all eight patients. Thus, at a dosage that should effectively inhibit adenosine receptors, aminophylline infusion exerts a beneficial effect on exercise-induced chest pain and ischemia-like ECG changes in syndrome X. This effect occurs possibly through the prevention of myocardial flow maldistribution elicited by inappropriate adenosine release during effort in the presence of increased coronary resistance at the level of small intramural coronary arteries. This study, however, does not document the ischemic nature of effort-induced pain and ECG alterations in syndrome X.
authors: Centro Nazionale delle Ricerche (C.N.R.), Institute of Clinical Physiology, Pisa, Italy.
authors: M
authors: M
authors: Emdin
authors: E
authors: E
authors: Picano
authors: F
authors: F
authors: Lattanzi
authors: A
authors: A
authors: L'Abbate
mesh_terms: D000328:Adult; D000628:Aminophylline / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy*; D004311:Double-Blind Method; D015444:Exercise; D005080:Exercise Test; D005260:Female; D006801:Humans; D008875:Middle Aged; D011897:Random Allocation; D013577:Syndrome
chemical_list: D000628:Aminophylline